July 29, 2015 (LifeSiteNews) - Health Canada has confirmed that it has approved the controversial abortion drug RU-486. Pro-life leaders say they are stunned by the news of the decision to expand abortion in a country where abortion on demand at taxpayer expense is already the norm.
Heavy bleeding, nausea, vomiting, and painful uterine contractions are common side-effects of the two-drug combo, which requires three trips to the doctor's office over a two week period.
As of 2011, fourteen U.S. women had died after taking RU-486 and a total of 2,207 reported adverse effects after using the drug, according to a report from the U.S. Food and Drug Administration.
A fact sheet on the drug by American Life League notes that RU stands for Roussel Uclaf, the manufacturer of the RU-486 pill. “Roussel Uclaf is owned by Hoechst A.G., one of several corporations spun off after World War II from the giant I. G. Farben chemical firm, the firm that supplied Hitler with the Zyklon B gas used to kill Jews and Christians in the Third Reich death camps,” they note.
Drug Watch: Yaz and Yasmin
Released in the United States in 2006, Yaz (drospirenone/ethinyl estradiol) is a birth control pill manufactured by Bayer. Yaz is a sister drug to Yasmin, which was approved in 2001. Both medications contain drospirenone/ethinyl estradiol, so they carry the same risk.
From 2008 to 2009, Yaz was the top-selling birth control pill in the United States. In April 2012, Yaz continued in popularity as the fourth best-selling oral contraceptive. Yet several studies show that Yaz puts women at an increased risk for blood clots. Blood clots can contribute to deep vein thrombosis (DVTs), pulmonary embolism (PE), stroke or heart attack.
On April 10, 2012, the FDA required Yaz to include a warning that drospirenone-containing pills increase the risk of blood clots by threefold. Also, a former FDA commissioner, David Kessler, filed an affidavit, claiming that Bayer withheld early reports of blood clots from the FDA in 2004.
A multidistrict litigation (MDL) has been set up in Illinois to handle the 10,000-plus lawsuits over Yaz and Yasmin side effects.
Thousands of pregnant women took the drug to relieve (morning sickness). At the time of the drug's development, scientists did not believe any drug taken by a pregnant woman could pass across the placental barrier and harm the developing foetus, even though the effect of alcohol on foetal development had been documented by case studies on alcoholic mothers since at least 1957.
Hence, while initially considered safe, the drug was responsible for teratogenic deformities in children born after their mothers used it during pregnancies, prior to the third trimester. In November 1961, thalidomide was taken off the market due to massive pressure from the press and public. Experts estimate that the drug thalidomide led to the death of approximately 2,000 children and serious birth defects in more than 10,000 children, about 5,000 of them in West Germany.
Deceptive marketing... it's happened before.
Thalidomide became one of the most successful prescription drugs in the history of medicine. In the UK, the British pharmaceutical company The Distillers Company (Biochemicals) Ltd, a subsidiary of Distillers Co. Ltd. (now part of Diageo plc), marketed thalidomide under the brand name Distaval® as a remedy for morning sickness throughout the United Kingdom, Australia and New Zealand. Their advertisement claimed that "Distaval can be given with complete safety to pregnant women and nursing mothers without adverse effect on mother or child... Outstandingly safe Distaval has been prescribed for nearly three years in this country."
In Canada, the history of the drug thalidomide dates back to April 1, 1961. There were many different forms sold, with the most common variant being Talimol. Two months after Talimol went on sale, pharmaceutical companies sent physicians letters warning about the risk of birth defects. It was not until March 2, 1962, that both drugs were banned from the Canadian market by the FDD, and soon afterward physicians were warned to destroy their supplies.
The drug thalidomide's birth defects in children affected many people's lives, and from these events came the formation of the group called The Thalidomide Victims Association of Canada, a group of 120 Canadian survivors.
The Society of Toxicology of Canada was formed after the effects of thalidomide were made public, focusing on toxicology as a discipline separate from pharmacology. The need for the testing and approval of the toxins in certain pharmaceutical drugs became more important after the disaster. The Society of Toxicology of Canada is responsible for the Conservation Environment Protection Act, focusing on researching the impact to human health of chemical substances.